StreetAlpha.app
Home › Stocks › JNJ

Johnson & Johnson (JNJ)

Healthcare
$278.75
▼ −1.34%
LAST CLOSE · NOV 17

Johnson & Johnson makes prescription medicines and medical devices for hospitals, doctors and eye care professionals. It last closed at $278.75 on Nov 17, down 1.34% on the day. JNJ reports earnings on Tue, Jan 26, 2027. The average 12-month price target from 8 analysts is $294.88 (+5.8% from the last close), with a high of $320.00 and a low of $272.00. Analyst consensus is Strong Buy, based on the latest ratings from 8 firms (7 buy, 1 hold, 0 sell). Over the past 90 days StreetAlpha recorded 5 whale options trades in JNJ, 60% of them bullish and 40% bearish. In the past 30 days there were 51 dark pool prints totaling $74.2M, the largest $20.0M. FLEX reports show 2 notable institutional FLEX trades in JNJ, totaling $12.5M in premium, the latest on Oct 29.

AI Auto Pilots
Is JNJ in one of our four AI portfolios? Sign in free to see

Key Stats

Last 12 months
Results
Revenue
$99.3B
+7.8% vs a year ago
Net income
$16.1B
−35.9% vs a year ago
EPS (diluted)
$6.58
−36.4% vs a year ago
Free cash flow
$20.6B
20.7% margin
Valuation
Market cap
$671B
2.41B shares
P/E
42.4
Price over 12 month EPS
Price to sales
6.8
Market cap over revenue
Dividend yield
1.89%
$5.28 a share over 12 months
Balance sheet
Cash & equivalents
$16.9B
At Sep 27
Debt
$35.8B
At Sep 27
Shareholder equity
$81.5B
Buybacks
$7.9B
Last 12 months
CEOJoaquin Duato
Employees138,200 (Nov 1, 2026)
Fiscal year endsJanuary
ExchangeNYSE
Financials history
FY2022: $78.7B$78.7BFY2022FY2023: $80.0B$80.0BFY2023FY2023: $85.2B$85.2BFY2023FY2024: $88.8B$88.8BFY2024FY2025: $94.2B$94.2BFY2025

From JNJ's SEC filings, latest 10-Q for the period ending Sep 27, 2026 (filed Oct 21). Last 12 months adds up the four latest quarters.

Next report
Jan 26
2027 · Time not announced
Consensus EPS forecast
$2.91
$26.42B revenue est.
Year-ago EPS
$2.46
Same quarter last year
Options-implied move
—
Posted about a week before
Analyst consensus
Strong Buy
Based on 8 analyst ratings (90 days)
Loading…

Analyst Ratings & Price Targets

Analyst Ratings →
Consensus · 90 days
Strong Buy
8firms
7 Buy1 Hold0 Sell
Each firm's latest rating on JNJ in the past 90 days
Average 12-month target
$294.88
▲ 5.8% upside

Based on 8 analysts who set a price target on JNJ in the past 90 days. The average target is $294.88, with a high of $320.00 and a low of $272.00, compared with the last close of $278.75.

$215$253$290$328PAST 112 TRADING DAYS12-MONTH TARGETSHIGH $320AVG $294.88LOW $272May 22LAST CLOSE+12 MO$215$253$290$328PAST 112 DAYSTARGETSHIGH $320AVG $294.88LOW $272May 22LAST CLOSE+12 MO
Highest target$320.00
Average target$294.88
Lowest target$272.00
Latest rating changes
Wells FargoTarget raised
Oct 16Buy$275 → $287
Morgan StanleyTarget lowered
Oct 15Buy$294 → $292
Leerink PartnersTarget raised
Oct 14Buy$265 → $272
Wells FargoTarget lowered
Oct 14Buy$282 → $275
RBC CapitalTarget lowered
Oct 14Buy$290 → $280
DateFirmActionRatingPrice target
Oct 16Wells FargoTarget raisedBuy$275 → $287
Oct 15Morgan StanleyTarget loweredBuy$294 → $292
Oct 14Leerink PartnersTarget raisedBuy$265 → $272
Oct 14Wells FargoTarget loweredBuy$282 → $275
Oct 14RBC CapitalTarget loweredBuy$290 → $280
Loading…

Technical Analysis

JNJ · as of the Nov 17 close · updated after every close
Uptrend

The stock is 2% above its 20 day and 4% above its 50 day average. It is 10% above its 200 day average, so the longer trend is still up. Momentum is strong (RSI 56). The nearest support is the Pivot S1 at $276.97, and the nearest resistance the Pivot at $279.34.

Short trendBullish
Long trendBullish
MomentumStrong
StretchNormal
VolatilityHigh, 2.4%/day
Key levels
$290.2552 week high+4.1%
$281.13Pivot R1+0.9%
$281.07Swing high (Sep 2)+0.8%
$279.34Pivot+0.2%
$278.75Last close
$276.97Pivot S1−0.6%
$273.9620 day average−1.7%
$267.2050 day average−4.1%
$265.28Swing low (Nov 3)−4.8%
$264.63100 day average−5.1%
$250.30200 day average−10.2%
$195.9052 week low−29.7%
Indicators
RSI (14)56.49Middle of its rangeNeutral
MACD5.09Above its signal lineBullish
Stochastic71.5Middle of its rangeNeutral
ADX (14)25.9Trending up
Williams %R-46.1Oversold below −80, overbought above −20Neutral
CCI (20)58.7Oversold below −100, overbought above 100Neutral
Rate of change+4.7%Change over 10 sessionsBullish
ATR (14)$6.76Typical daily range, 2.4% of price
MA 10Below
MA 20Above
MA 50Above
MA 100Above
MA 200Above
What happened before, for JNJ

What happened before

See how JNJ did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.

Whale flow leans bullish3 bullish and 2 bearish whale options trades in the last 90 days. See Whale Flow
November seasonalityHow JNJ usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

Seasonality

How JNJ has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2006.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D
Total alerts
5
Bullish
3
60%
Bearish
2
40%
Date span
Sep 3 – Nov 11
Loading…

See today’s whale options flow across the market →

Dark Pool

30D
Prints
51
Notional
$74.2M
Largest print
$20.0M
Loading…

FLEX Options Activity

FLEX Flow →
Notable FLEX trades
2
$12.5M premium
Validated
0 of 0 resolved
2 still open
Single-leg prints · 30D
7
$5K premium · + 32 multi-leg
Latest report
Oct 29

FLEX options are customized, exchange-listed contracts used mostly by institutions. StreetAlpha scans the daily FLEX report for unusually large, long-dated positions. Multi-leg structures, such as paired calls and puts used for financing or hedging, are listed but not counted in these totals.

Loading…

JNJ Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Neutral
Strongly bearishNeutralStrongly bullish
  • ●2,068 buying vs 1,996 selling
  • ▼Held by funds -1.8 pts
  • ●Funds holding +10
  • ▼Superinvestors: 1 added, 2 cut
  • ▲Put/call 1.32 to 1.01
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding4,7114,701+0.2%
In funds' top 10323296+9.1%
Held by funds73.6%75.4%−1.8 pts
New / increased169 / 1,899154 / 1,955−1.9%
Reduced / sold out1,895 / 1011,863 / 120+0.7%
Put/call ratio1.011.32−23.3%
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See JNJ institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

JNJ Stock Buybacks

See all S&P 500 buybacks →
Spent, 12 months
$7.9B
1.2% yield
Left in program
—
 
Shares outstanding, 12 months
−0.1%
Fewer shares
Last quarter
$1.7B
Sep 2026
Avg price paid, last quarter
—
6.5M shares bought
S&P 500 rank by spending
#25 of 358
 
Spent each quarter, last 3 yearsTop bar $4.0B
Dec 2023: $216.8M, average price $155.94Mar 2024: $1.5BJun 2024: $135.2MSep 2024: $539.1MDec 2024: $256.6M, average price $160.03Mar 2025: $2.1BJun 2025: $0Sep 2025: $1.9BDec 2025: $1.9B, average price $197.89Mar 2026: $4.0BJun 2026: $222.7MSep 2026: $1.7B
Dec 2023Sep 2026
For membersMonth by month buying, shares and the average price paid each month are shown to AI Starter and AI Pro members.

From the company's 10-Q filed Oct 21, 2026. Quarters are the company's own fiscal quarters. Yield and % of value use the latest close. Buybacks are not a forecast: in our testing, the biggest buyers did about the same as the average S&P 500 stock.

AI Auto Pilots

Paper trading

StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether JNJ is in one of them and how their past JNJ trades turned out.

JNJ in the AI portfolios
Loading…

JNJ News Tone and Price

Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered JNJ in an article yet. Here's the latest on the wider market.

JNJ Congress Trades

All congress trades →
Trades, 12 months
52
Buys
24
46%
Sells
28
54%
People
11
Last filed Nov 9
Who traded JNJ · since 2014
Latest 5 filings of 343
$100K – $250KTraded Oct 7, 2026Filed Nov 9, 2026
$50K – $100KTraded Oct 7, 2026Filed Nov 5, 2026
Thomas KeanSell (partial)
$1K – $15KTraded Sep 30, 2026Filed Oct 30, 2026
$1K – $15KTraded Sep 25, 2026Filed Oct 7, 2026
$15K – $50KTraded Sep 4, 2026Filed Oct 7, 2026
PersonTypeAmountTradedFiledDelay
Ro KhannaD · CASell$100K – $250KOct 7, 2026Nov 9, 202633 d
Ro KhannaD · CASell$50K – $100KOct 7, 2026Nov 5, 202629 d
Thomas KeanR · NJSell (partial)$1K – $15KSep 30, 2026Oct 30, 202630 d
Ro KhannaD · CABuy$1K – $15KSep 25, 2026Oct 7, 202612 d
Ro KhannaD · CABuy$15K – $50KSep 4, 2026Oct 7, 202633 d

Members of Congress and senior officials report trades up to 45 days later, as dollar ranges. Filings show a trade happened, not why. Not investment advice.

About Johnson & Johnson

Johnson & Johnson is a healthcare company based in New Brunswick, New Jersey, that researches, makes and sells medicines and medical devices. Its Innovative Medicine business offers prescription drugs for conditions such as cancer, immune disorders, mental health conditions, HIV and pulmonary arterial hypertension. Its MedTech business supplies products for heart care, surgery, orthopaedic procedures and vision care. Its customers include hospitals, doctors, retailers, wholesalers and eye care professionals, and it sells in virtually all countries.

Headquarters
New Brunswick, NJ
Founded
1886